{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T05:10:20Z","timestamp":1702703420893},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2023,12,15]]},"DOI":"10.2169\/internalmedicine.1693-23","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T22:14:18Z","timestamp":1682028858000},"page":"3585-3590","source":"Crossref","is-referenced-by-count":0,"title":["Long-term Follow-up of Small Nonfunctioning Pancreatic Neuroendocrine Tumors Diagnosed Using Endoscopic Ultrasound-guided Fine-needle Aspiration"],"prefix":"10.2169","volume":"62","author":[{"given":"Yuichi","family":"Takano","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masataka","family":"Yamawaki","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Noda","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsushi","family":"Azami","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumitaka","family":"Niiya","sequence":"additional","affiliation":[{"name":"Division of Endoscopy, Shizuoka Cancer Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naotaka","family":"Maruoka","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Yamagami","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Norose","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Ohike","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatsugu","family":"Nagahama","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ito T, Masui T, Komoto I, et al. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. J Gastroenterol 56: 1033-1044, 2021.","DOI":"10.1007\/s00535-021-01827-7"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Sadot E, Reidy-Lagunes DL, Tang LH, et al. Observation versus resection for small asymptomatic pancreatic neuroendocrine tumors: a matched case-control study. Ann Surg Oncol 23: 1361-1370, 2016.","DOI":"10.1245\/s10434-015-4986-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Lee LC, Grant CS, Salomao DR, et al. Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management. Surgery 152: 965-974, 2012.","DOI":"10.1016\/j.surg.2012.08.038"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gaujoux S, Partelli S, Maire F, et al. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. J Clin Endocrinol Metab 98: 4784-4789, 2013.","DOI":"10.1210\/jc.2013-2604"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Jung JG, Lee KT, Woo YS, et al. Behavior of small, asymptomatic, nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs). Medicine (Baltimore) 94: e983, 2015.","DOI":"10.1097\/MD.0000000000000983"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Crippa S, Partelli S, Zamboni G, et al. Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors. Surgery 155: 145-153, 2014.","DOI":"10.1016\/j.surg.2013.08.002"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kishi Y, Shimada K, Nara S, Esaki M, Hiraoka N, Kosuge T. Basing treatment strategy for non-functional pancreatic neuroendocrine tumors on tumor size. Ann Surg Oncol 21: 2882-2888, 2014.","DOI":"10.1245\/s10434-014-3701-y"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kimura W, Miyata H, Gotoh M, et al. A pancreaticoduodenectomy risk model derived from 8575 cases from a national single-race population (Japanese) using a web-based data entry system: the 30-day and in-hospital mortality rates for pancreaticoduodenectomy. Ann Surg 259: 773-780, 2014.","DOI":"10.1097\/SLA.0000000000000263"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Falconi M, Eriksson B, Kaltsas G, et al.; all other Vienna Consensus Conference participants. ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology 103: 153-171, 2016.","DOI":"10.1159\/000443171"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sallinen V, Haglund C, Sepp\u00e4nen H. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: do size and symptoms matter? Surgery 158: 1556-1563, 2015.","DOI":"10.1016\/j.surg.2015.04.035"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ricci C, Casadei R, Taffurelli G, et al. Sporadic small (\u226420 mm) nonfunctioning pancreatic neuroendocrine neoplasm: is the risk of malignancy negligible when adopting a more conservative strategy? A systematic review and meta-analysis. Ann Surg Oncol 24: 2603-2610, 2017.","DOI":"10.1245\/s10434-017-5946-8"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ito T, Hijioka S, Masui T, et al. Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan. J Gastroenterol 52: 9-18, 2017.","DOI":"10.1007\/s00535-016-1250-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zilli A, Arcidiacono PG, Conte D, Massironi S. Clinical impact of endoscopic ultrasonography on the management of neuroendocrine tumors: lights and shadows. Dig Liver Dis 50: 6-14, 2018.","DOI":"10.1016\/j.dld.2017.10.007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pezzilli R, Partelli S, Cannizzaro R, et al. Ki-67 prognostic and therapeutic decision driven marker for pancreatic neuroendocrine neoplasms (PNENs): a systematic review. Adv Med Sci 61: 147-153, 2016.","DOI":"10.1016\/j.advms.2015.10.001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hasegawa T, Yamao K, Hijioka S, et al. Evaluation of Ki-67 index in EUS-FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors. Endoscopy 46: 32-38, 2014.","DOI":"10.1055\/s-0033-1344958"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Fujimori N, Osoegawa T, Lee L, et al. Efficacy of endoscopic ultrasonography and endoscopic ultrasonography-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors. Scand J Gastroenterol 51: 245-252, 2016.","DOI":"10.3109\/00365521.2015.1083050"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Unno J, Kanno A, Masamune A, et al. The usefulness of endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of pancreatic neuroendocrine tumors based on the World Health Organization classification. Scand J Gastroenterol 49: 1367-1374, 2014.","DOI":"10.3109\/00365521.2014.934909"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Poultsides GA, Huang LC, Chen Y, et al. Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis. Ann Surg Oncol 19: 2295-2303, 2012.","DOI":"10.1245\/s10434-012-2305-7"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Mizumoto T, Toyama H, Terai S, et al. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics. Pancreatology 17: 956-961, 2017.","DOI":"10.1016\/j.pan.2017.08.003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Nanno Y, Matsumoto I, Zen Y, et al. Pancreatic duct involvement in well-differentiated neuroendocrine tumors is an independent poor prognostic factor. Ann Surg Oncol 24: 1127-1133, 2017.","DOI":"10.1245\/s10434-016-5663-8"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/24\/62_1693-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T03:20:04Z","timestamp":1702696804000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/62\/24\/62_1693-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":20,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1693-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"article-number":"1693-23"}}